Pfizer stock heads toward record after $6.7 billion takeover of Arena; deal ‘makes strategic sense to us,’ says analyst

Pfizer Inc. said Monday it has agreed to acquire Arena Pharmaceuticals Inc. in a deal with a value of about $6.7 billion, sending both stocks sharply higher.